{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:36:54Z","timestamp":1761100614255},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2003,4,1]]},"DOI":"10.1038\/sj.bmt.1703881","type":"journal-article","created":{"date-parts":[[2003,4,11]],"date-time":"2003-04-11T15:28:15Z","timestamp":1050074895000},"page":"591-597","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment"],"prefix":"10.1038","volume":"31","author":[{"given":"R P S","family":"Bajwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A J","family":"Cant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Abinun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T J","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J P","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,4,11]]},"reference":[{"key":"BF1703881_CR1","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1525-1594.1996.tb00652.x","volume":"20","author":"K Watanabe","year":"1996","unstructured":"Watanabe K, Iwaki H, Satoh M et al. Veno-occlusive disease of the liver following bone marrow transplantation: a clinical-pathological study of autopsy cases. Artif Organs 1996; 20: 1145\u20131150.","journal-title":"Artif Organs"},{"key":"BF1703881_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.bmt.1701445","volume":"22","author":"J-H Lee","year":"1998","unstructured":"Lee J-H, Lee K-H, Kim S et al. Relevance of proteins C and S, antithrombin III, Von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant 1998; 22: 883\u2013888.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703881_CR3","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","volume":"11","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Anderson GL, Mori M et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729\u20131736.","journal-title":"J Clin Oncol"},{"key":"BF1703881_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multi organ failure after bone marrow transplantation \u2013 a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BF1703881_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/sj.bmt.1701654","volume":"23","author":"S Kulkarni","year":"1999","unstructured":"Kulkarni S, Rodriguez M, Lafuente A et al. Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (HVOD). Bone Marrow Transplant 1999; 23: 803\u2013807.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703881_CR6","first-page":"737","volume":"92","author":"P Richardson","year":"1998","unstructured":"Richardson P, Elais ED, Krishnan A et al. Treatment of severe Veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high risk population. Blood 1998; 92: 737\u2013744.","journal-title":"Blood"},{"issue":"Suppl 2","key":"BF1703881_CR7","first-page":"157","volume":"18","author":"R Miniero","year":"1996","unstructured":"Miniero R, Vassallo E, Soldano S et al. Management of hepatic veno-occlusive disease in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematolgy Oncology Association-Bone Marrow Transplantation group) centers. Bone Marrow Transplant 1996; 18(Suppl 2): 157\u2013159.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703881_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschorer WE et al. Venocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778\u2013783.","journal-title":"Transplantation"},{"key":"BF1703881_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/00003246-198604000-00002","volume":"14","author":"JD Wilkinson","year":"1986","unstructured":"Wilkinson JD, Pollack MM, Ruttimann UE et al. Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986; 14: 271\u2013274.","journal-title":"Crit Care Med"},{"key":"BF1703881_CR10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s002770050321","volume":"75","author":"W N\u00fcnberger","year":"1997","unstructured":"N\u00fcnberger W, Heying R, Burdach S et al. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 1997; 75: 95\u2013101.","journal-title":"Ann Hematol"},{"key":"BF1703881_CR11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/sj.bmt.1702069","volume":"24","author":"J Schriber","year":"1999","unstructured":"Schriber J, Milk B, Shaw D et al. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation. Bone Marrow Transplant 1999; 24: 1311\u20131314.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703881_CR12","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1182\/blood.V89.5.1501","volume":"89","author":"SI Bearman","year":"1997","unstructured":"Bearman SI, Lee JL, Baron AE et al. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 1997; 89: 1501\u20131506.","journal-title":"Blood"},{"issue":"Suppl 1","key":"BF1703881_CR13","first-page":"632a","volume":"10","author":"RK Goyal","year":"1993","unstructured":"Goyal RK, Wall DA, Yu LC et al. Identification of patients with hepatic venoocclusive disease likely to respond to rtPA therapy. Blood 1993; 10(Suppl 1): 632a (abstract).","journal-title":"Blood"},{"key":"BF1703881_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116.","journal-title":"Hepatology"},{"key":"BF1703881_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.bmt.1700985","volume":"20","author":"JD Morris","year":"1997","unstructured":"Morris JD, Harris RE, Hashmi R et al. Anti-thrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. Bone Marrow Transplant 1997; 20: 871\u2013878.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703881_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/0140-6736(93)91646-4","volume":"342","author":"M Eltumi","year":"1993","unstructured":"Eltumi M, Trivedi P, Hobbs JR et al. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet 1993; 342: 518\u2013521.","journal-title":"Lancet"},{"key":"BF1703881_CR17","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.bmt.1702624","volume":"26","author":"S Tanikawa","year":"2000","unstructured":"Tanikawa S, Mori S, Ohhashi K et al. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study. Bone Marrow Transplant 2000; 26: 881\u2013886.","journal-title":"Bone Marrow Transplant"},{"key":"BF1703881_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.bmt.1700689","volume":"19","author":"C Salat","year":"1997","unstructured":"Salat C, Holler E, Wolf C et al. Laboratory markers of veno-occlusive disease in the course of bone marrow transplantation. Bone Marrow Transplant 1997; 19: 487\u2013490.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703881","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703881.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T23:28:23Z","timestamp":1648078103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,1]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,4,1]]}},"alternative-id":["BF1703881"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703881","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,1]]},"assertion":[{"value":"8 April 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}